Padhye A A, Bennett J E, McGinnis M R, Sigler L, Fliss A, Salkin I F
Mycotic Diseases Branch, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Med Mycol. 1998;36 Suppl 1:258-65.
Over 500,000 workers in the USA alone are employed in laboratories that range from small physician offices to large clinical laboratories handling microbes for comprehensive research and/or diagnostic work. These workers are exposed to a variety of potential occupational health risks such as exposure to infectious clinical materials, environmental specimens, cultures, complex and inflammable chemicals, radiation, and electrical and mechanical hazards. As members of the International Society for Human and Animal Mycology, we have no policy statement on biosafety standards for handling medically important fungi. The intent of the symposium is to cover some of the important aspects of biosafety; (1) standards in handling dimorphic fungal pathogens; (2) the principles and criteria of biosafety levels and classification of known medically important fungi, aerobic actinomycetes, environmental fungi according to their biosafety levels; (3) medically important fungal waste and its safe disposal; and (4) biosafety and regulatory considerations in handling and mailing medically important fungi in a culture collection.
仅在美国,就有超过50万名工人受雇于各类实验室,这些实验室规模不一,从小型医生办公室到大型临床实验室,后者负责处理微生物以进行全面研究和/或诊断工作。这些工人面临各种潜在的职业健康风险,如接触传染性临床材料、环境标本、培养物、复杂且易燃的化学品、辐射以及电气和机械危险。作为国际人类和动物真菌学会的成员,我们没有关于处理医学上重要真菌的生物安全标准的政策声明。本次研讨会的目的是涵盖生物安全的一些重要方面:(1)处理双相真菌病原体的标准;(2)生物安全水平的原则和标准以及已知医学上重要真菌、需氧放线菌、环境真菌根据其生物安全水平的分类;(3)医学上重要的真菌废物及其安全处置;(4)在菌种保藏中心处理和邮寄医学上重要真菌时的生物安全和监管考量。